Citius Pharmaceuticals, Inc. CTXR

NASDAQ Price as of Nov 6, 2026 · Fiscal year ended Sep 30, 2025 · Latest quarter Jun 30, 2026

$0.5600
$0.3700
$1.54
Market cap
$15.37M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
—
EPS growth YoY
57.5%
ROIC
-48.1%
Piotroski F-score
4

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) — —— ——
EPS growth YoY (qtr) 57.5% 25.2%+32.3 pts ——
Revenue growth (TTM) — —— ——
EPS growth (TTM) 66.3% 62.8%+3.5 pts ——
P/E (GAAP, TTM) — —— ——
P/E (operating) — —— ——
P/E (excl. gains) — —— ——
P/B 0.09 0.10-0.01 ——
ROIC -48.1% -48.1%0.0 pts ——
Net margin — —— ——
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -1.68 -2.14+21.5% ——
Price $0.5400 $0.6100-11.5% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Jun 30, 2026 $1.49M -10.4% — -0.34 64.2% 57.5% -797.9%
Mar 31, 2026 $1.67M -57.7% — -0.95 -150.0% 25.2% -1,685.9%
Dec 31, 2025 $3.94M — — -0.38 -3,700.0% 70.8% -238.2%
Sep 30, 2025 * — — — -0.01 98.8% 99.4% —
Jun 30, 2025 — — — -0.80 37.0% 49.0% —
Mar 31, 2025 — — — -1.27 2.3% 5.2% —
Dec 31, 2024 — — — -1.30 19.3% 10.3% —
Sep 30, 2024 * — — — -1.61 -2.5% 70.3% —
Jun 30, 2024 — — — -1.57 -17.2% -2,516.7% —
Mar 31, 2024 — — — -1.34 7.6% -1,814.3% —
Dec 31, 2023 — — — -1.45 73.2% -7,150.0% —
Sep 30, 2023 * — — — -5.42 -8,933.3% -8,933.3% —

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Sep 30, 2025 End date of the latest annual (10-K) report used.
Price date Nov 6, 2026 Date of the latest closing price used.
Price $0.5600 Latest closing price.
Market cap $15.37M Price × shares outstanding.
Enterprise value $11.12M Market cap + debt − cash: the price of the whole business.
Shares 27.45M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -258.5% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -300.0% TTM EPS ÷ price.
P/B 0.23 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S — Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) — Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales — Enterprise value ÷ revenue.
Book value / share 2.46 Shareholders' equity ÷ shares.
FCF yield -172.7% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS -1.11 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income -$157.70K Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Jun 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $1.49M Revenue of the latest reported quarter.
Net income (qtr) -$11.92M Net income of the latest reported quarter.
EPS (qtr) -0.34 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) — Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -10.4% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 57.5% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 64.2% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -29.5% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 57.6% Latest quarter net income vs the previous quarter.
Gross margin (qtr) 67.1% Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -785.4% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -797.9% Net income ÷ revenue in the latest quarter.
Revenue (TTM) — Revenue of the last four quarters.
Net income (TTM) -$58.17M Net income of the last four quarters.
EPS (TTM) -1.68 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) — Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 66.3% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 3.9% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin — EBITDA ÷ revenue.
Operating margin — Operating income ÷ revenue.
Net margin — Net income ÷ revenue.
FCF margin — Free cash flow ÷ revenue.
ROE -58.8% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -30.4% Return on assets: net income ÷ total assets.
ROIC -48.1% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) — Latest fiscal year revenue vs the year before.
Net income growth (annual) -0.8% Latest fiscal year net income vs the year before.
EPS growth (annual) 43.4% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) — Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 0.62 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 0.13 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.09 Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage -774.38 Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -10.1% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue — Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover — Revenue ÷ total assets.
Days sales outstanding — Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $1.54 Highest price in the last 52 weeks.
52-week low $0.3700 Lowest price in the last 52 weeks.
From 52-week high -63.6% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 51.4% How far above the 52-week low the price is.
Avg volume (30d) 254.40K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $121.42K Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 4 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score — Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue — Revenue of the latest fiscal year.
Net income -$39.74M Net income of the latest fiscal year.
Diluted EPS -3.38 Diluted earnings per share of the latest fiscal year.
EBITDA -$38.53M Operating income + depreciation & amortization.
Free cash flow -$26.55M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $4.25M Cash and equivalents.
Equity $67.55M Shareholders' equity.
Total assets $130.94M Total assets.